首页 > 最新文献

Circulation-Cardiovascular Quality and Outcomes最新文献

英文 中文
Home Health Care Use and Outcomes After Coronary Artery Bypass Grafting Among Medicare Beneficiaries. 医疗保险受益人在冠状动脉旁路移植术后使用家庭医疗护理的情况和结果。
IF 6.2 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-07-01 Epub Date: 2024-05-21 DOI: 10.1161/CIRCOUTCOMES.123.010459
Michael P Thompson, Hechuan Hou, Donald S Likosky, Francis D Pagani, Jason R Falvey, Kathryn H Bowles, Rishi K Wadhera, Madeline R Sterling

Background: Home health care (HHC) has been increasingly used to improve care transitions and avoid poor outcomes, but there is limited data on its use and efficacy following coronary artery bypass grafting. The purpose of this study was to describe HHC use and its association with outcomes among Medicare beneficiaries undergoing coronary artery bypass grafting.

Methods: Retrospective analysis of 100% of Medicare fee-for-service files identified 77 331 beneficiaries undergoing coronary artery bypass grafting and discharged to home between July 2016 and December 2018. The primary exposure of HHC use was defined as the presence of paid HHC claims within 30 days of discharge. Hierarchical logistic regression identified predictors of HHC use and the percentage of variation in HHC use attributed to the hospital. Propensity-matched logistic regression compared mortality, readmissions, emergency department visits, and cardiac rehabilitation enrollment at 30 and 90 days after discharge between HHC users and nonusers.

Results: A total of 26 751 (34.6%) of beneficiaries used HHC within 30 days of discharge, which was more common among beneficiaries who were older (72.9 versus 72.5 years), male (79.4% versus 77.4%), White (90.2% versus 89.2%), and not Medicare-Medicaid dual eligible (6.7% versus 8.8%). The median hospital-level rate of HHC use was 31.0% (interquartile range, 13.7%-54.5%) and ranged from 0% to 94.2%. Nearly 30% of the interhospital variation in HHC use was attributed to the discharging hospital (intraclass correlation coefficient, 0.296 [95% CI, 0.275-0.318]). Compared with non-HHC users, those using HHC were less likely to have a readmission or emergency department visit, were more likely to enroll in cardiac rehabilitation, and had modestly higher mortality within 30 or 90 days of discharge.

Conclusions: A third of Medicare beneficiaries undergoing coronary artery bypass grafting used HHC within 30 days of discharge, with wide interhospital variation in use and mixed associations with clinical outcomes and health care utilization.

背景:家庭健康护理(HHC)越来越多地被用于改善护理过渡和避免不良预后,但有关其在冠状动脉旁路移植术后的使用和效果的数据却很有限。本研究旨在描述接受冠状动脉搭桥术的医疗保险受益人使用 HHC 的情况及其与治疗效果的关系:对100%的医疗保险收费服务档案进行回顾性分析,确定了77 331名在2016年7月至2018年12月期间接受冠状动脉搭桥术并出院回家的受益人。HHC使用的主要暴露定义为出院后30天内存在付费的HHC索赔。分层逻辑回归确定了使用 HHC 的预测因素以及归因于医院的 HHC 使用变化百分比。倾向匹配逻辑回归比较了使用和未使用 HHC 的患者在出院后 30 天和 90 天内的死亡率、再入院率、急诊就诊率和心脏康复就诊率:共有 26 751 名受益人(34.6%)在出院后 30 天内使用过 HHC,其中年龄较大(72.9 岁对 72.5 岁)、男性(79.4% 对 77.4%)、白人(90.2% 对 89.2%)和非医疗保险-医疗补助双重资格(6.7% 对 8.8%)的受益人使用 HHC 的比例更高。医院一级的 HHC 使用率中位数为 31.0%(四分位间范围为 13.7%-54.5%),介于 0% 与 94.2% 之间。HHC使用率的医院间差异有近30%归因于出院医院(类内相关系数,0.296 [95% CI,0.275-0.318])。与未使用 HHC 的患者相比,使用 HHC 的患者再次入院或到急诊科就诊的可能性较低,更有可能参加心脏康复治疗,出院后 30 天或 90 天内的死亡率略高:三分之一接受冠状动脉旁路移植术的医疗保险受益人在出院后30天内使用了HHC,医院之间的使用情况差异很大,与临床结果和医疗保健利用率的关系也不尽相同。
{"title":"Home Health Care Use and Outcomes After Coronary Artery Bypass Grafting Among Medicare Beneficiaries.","authors":"Michael P Thompson, Hechuan Hou, Donald S Likosky, Francis D Pagani, Jason R Falvey, Kathryn H Bowles, Rishi K Wadhera, Madeline R Sterling","doi":"10.1161/CIRCOUTCOMES.123.010459","DOIUrl":"10.1161/CIRCOUTCOMES.123.010459","url":null,"abstract":"<p><strong>Background: </strong>Home health care (HHC) has been increasingly used to improve care transitions and avoid poor outcomes, but there is limited data on its use and efficacy following coronary artery bypass grafting. The purpose of this study was to describe HHC use and its association with outcomes among Medicare beneficiaries undergoing coronary artery bypass grafting.</p><p><strong>Methods: </strong>Retrospective analysis of 100% of Medicare fee-for-service files identified 77 331 beneficiaries undergoing coronary artery bypass grafting and discharged to home between July 2016 and December 2018. The primary exposure of HHC use was defined as the presence of paid HHC claims within 30 days of discharge. Hierarchical logistic regression identified predictors of HHC use and the percentage of variation in HHC use attributed to the hospital. Propensity-matched logistic regression compared mortality, readmissions, emergency department visits, and cardiac rehabilitation enrollment at 30 and 90 days after discharge between HHC users and nonusers.</p><p><strong>Results: </strong>A total of 26 751 (34.6%) of beneficiaries used HHC within 30 days of discharge, which was more common among beneficiaries who were older (72.9 versus 72.5 years), male (79.4% versus 77.4%), White (90.2% versus 89.2%), and not Medicare-Medicaid dual eligible (6.7% versus 8.8%). The median hospital-level rate of HHC use was 31.0% (interquartile range, 13.7%-54.5%) and ranged from 0% to 94.2%. Nearly 30% of the interhospital variation in HHC use was attributed to the discharging hospital (intraclass correlation coefficient, 0.296 [95% CI, 0.275-0.318]). Compared with non-HHC users, those using HHC were less likely to have a readmission or emergency department visit, were more likely to enroll in cardiac rehabilitation, and had modestly higher mortality within 30 or 90 days of discharge.</p><p><strong>Conclusions: </strong>A third of Medicare beneficiaries undergoing coronary artery bypass grafting used HHC within 30 days of discharge, with wide interhospital variation in use and mixed associations with clinical outcomes and health care utilization.</p>","PeriodicalId":49221,"journal":{"name":"Circulation-Cardiovascular Quality and Outcomes","volume":" ","pages":"e010459"},"PeriodicalIF":6.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11251853/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141071711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
American Heart Association Cardiogenic Shock Registry: Design and Implementation. 美国心脏协会心源性休克登记处:设计与实施。
IF 6.2 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-07-01 Epub Date: 2024-06-18 DOI: 10.1161/CIRCOUTCOMES.123.010637
David A Morrow, Mariell Jessup, William T Abraham, Michael Acker, Angeline Aringo, Wayne Batchelor, Joanna Chikwe, Shaina Costello, Stavros G Drakos, Steven Farmer, Annetine Gelijns, Nicole Gillette, Judith S Hochman, Maria Isler, Navin K Kapur, Arman Kilic, Robert Kormos, Eldrin F Lewis, JoAnn Lindenfeld, Pierluca Lombardi, Donna Mancini, Sunil V Rao, Christine Rutan, Marc Samsky, Mitchell W Krucoff

Background: Cardiogenic shock is a morbid complication of heart disease that claims the lives of more than 1 in 3 patients presenting with this syndrome. Supporting a unique collaboration across clinical specialties, federal regulators, payors, and industry, the American Heart Association volunteers and staff have launched a quality improvement registry to better understand the clinical manifestations of shock phenotypes, and to benchmark the management patterns, and outcomes of patients presenting with cardiogenic shock to hospitals across the United States.

Methods: Participating hospitals will enroll consecutive hospitalized patients with cardiogenic shock, regardless of etiology or severity. Data are collected through individual reviews of medical records of sequential adult patients with cardiogenic shock. The electronic case record form was collaboratively designed with a core minimum data structure and aligned with Shock Academic Research Consortium definitions. This registry will allow participating health systems to evaluate patient-level data including diagnostic approaches, therapeutics, use of advanced monitoring and circulatory support, processes of care, complications, and in-hospital survival. Participating sites can leverage these data for onsite monitoring of outcomes and benchmarking versus other institutions. The registry was concomitantly designed to provide a high-quality longitudinal research infrastructure for pragmatic randomized trials as well as translational, clinical, and implementation research. An aggregate deidentified data set will be made available to the research community on the American Heart Association's Precision Medicine Platform. On March 31, 2022, the American Heart Association Cardiogenic Shock Registry received its first clinical records. At the time of this submission, 100 centers are participating.

Conclusions: The American Heart Association Cardiogenic Shock Registry will serve as a resource using consistent data structure and definitions for the medical and research community to accelerate scientific advancement through shared learning and research resulting in improved quality of care and outcomes of shock patients.

背景:心源性休克是心脏病的一种病态并发症,每 3 个出现这种综合征的患者中就有 1 人因此而丧生。在临床专科、联邦监管机构、支付方和业界的独特合作支持下,美国心脏协会的志愿者和工作人员发起了一项质量改进登记计划,以更好地了解休克表型的临床表现,并为全美医院心源性休克患者的管理模式和治疗效果制定基准:方法:参与医院将招募连续住院的心源性休克患者,无论其病因或严重程度如何。通过对连续的心源性休克成年患者的病历进行逐一审查来收集数据。电子病例记录表是根据休克学术研究联盟的定义和最低核心数据结构共同设计的。该登记册将使参与的医疗系统能够评估患者层面的数据,包括诊断方法、治疗方法、高级监护和循环支持的使用、护理流程、并发症和院内存活率。参与的医疗机构可以利用这些数据对结果进行现场监测,并与其他机构进行比较。同时,登记处还旨在为实用随机试验以及转化、临床和实施研究提供高质量的纵向研究基础设施。将在美国心脏协会的精准医学平台上向研究界提供汇总的去标识化数据集。2022 年 3 月 31 日,美国心脏协会心源性休克注册中心收到了第一批临床记录。截至本报告提交时,已有 100 家中心参与其中:美国心脏协会心源性休克登记处将成为医疗和研究界使用一致数据结构和定义的资源,通过共享学习和研究加速科学进步,从而提高休克患者的护理质量和预后。
{"title":"American Heart Association Cardiogenic Shock Registry: Design and Implementation.","authors":"David A Morrow, Mariell Jessup, William T Abraham, Michael Acker, Angeline Aringo, Wayne Batchelor, Joanna Chikwe, Shaina Costello, Stavros G Drakos, Steven Farmer, Annetine Gelijns, Nicole Gillette, Judith S Hochman, Maria Isler, Navin K Kapur, Arman Kilic, Robert Kormos, Eldrin F Lewis, JoAnn Lindenfeld, Pierluca Lombardi, Donna Mancini, Sunil V Rao, Christine Rutan, Marc Samsky, Mitchell W Krucoff","doi":"10.1161/CIRCOUTCOMES.123.010637","DOIUrl":"10.1161/CIRCOUTCOMES.123.010637","url":null,"abstract":"<p><strong>Background: </strong>Cardiogenic shock is a morbid complication of heart disease that claims the lives of more than 1 in 3 patients presenting with this syndrome. Supporting a unique collaboration across clinical specialties, federal regulators, payors, and industry, the American Heart Association volunteers and staff have launched a quality improvement registry to better understand the clinical manifestations of shock phenotypes, and to benchmark the management patterns, and outcomes of patients presenting with cardiogenic shock to hospitals across the United States.</p><p><strong>Methods: </strong>Participating hospitals will enroll consecutive hospitalized patients with cardiogenic shock, regardless of etiology or severity. Data are collected through individual reviews of medical records of sequential adult patients with cardiogenic shock. The electronic case record form was collaboratively designed with a core minimum data structure and aligned with Shock Academic Research Consortium definitions. This registry will allow participating health systems to evaluate patient-level data including diagnostic approaches, therapeutics, use of advanced monitoring and circulatory support, processes of care, complications, and in-hospital survival. Participating sites can leverage these data for onsite monitoring of outcomes and benchmarking versus other institutions. The registry was concomitantly designed to provide a high-quality longitudinal research infrastructure for pragmatic randomized trials as well as translational, clinical, and implementation research. An aggregate deidentified data set will be made available to the research community on the American Heart Association's Precision Medicine Platform. On March 31, 2022, the American Heart Association Cardiogenic Shock Registry received its first clinical records. At the time of this submission, 100 centers are participating.</p><p><strong>Conclusions: </strong>The American Heart Association Cardiogenic Shock Registry will serve as a resource using consistent data structure and definitions for the medical and research community to accelerate scientific advancement through shared learning and research resulting in improved quality of care and outcomes of shock patients.</p>","PeriodicalId":49221,"journal":{"name":"Circulation-Cardiovascular Quality and Outcomes","volume":" ","pages":"e010637"},"PeriodicalIF":6.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141421552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health-Status Outcomes in Older Patients With Myocardial Infarction: Physiology-Guided Complete Revascularization Versus Culprit-Only Strategy. 老年心肌梗死患者的健康状况结果:生理学指导下的完全血管再通术与仅针对病灶的策略。
IF 6.2 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-07-01 Epub Date: 2024-06-18 DOI: 10.1161/CIRCOUTCOMES.123.010490
Gianluca Campo, Vincenzo Guiducci, Javier Escaned, Raul Moreno, Gianni Casella, Caterina Cavazza, Enrico Cerrato, Marco Contarini, Marco Arena, Andres Iniguez Romo, Enrique Gutiérrez Ibañes, Roberto Scarsini, Giuseppe Vadalà, Giuseppe Andò, Gerlando Pilato, Sergio Musto d'Amore, Alessandro Capecchi, Ramiro Trillo Nouche, Elisabetta Moscarella, Alfonso Gambino, Marco Pavani, Anna Zanetti, Nicola Pesenti, Dariusz Dudek, Emanuele Barbato, Matteo Tebaldi, Simone Biscaglia

Background: The FIRE trial (Functional Assessment in Elderly Myocardial Infarction Patients With Multivessel Disease) enrolled 1445 older (aged ≥75 years) patients with myocardial infarction and multivessel disease in Italy, Spain, and Poland. Patients were randomized to physiology-guided complete revascularization or treatment of the only culprit lesion. Physiology-guided complete revascularization significantly reduced ischemic adverse events at 1 year. This prespecified analysis investigated the changes between the 2 study groups in angina status, quality of life, physical performance, and frailty.

Methods: Patients underwent validated scales at hospital discharge (baseline) and 1 year later. Angina status was evaluated using the Seattle Angina Questionnaire, health-related quality of life by EQ visual analog scale, physical performance by short physical performance battery, and frailty by the clinical frailty scale. Mixed models for repeated measures analysis were used to study the association between the treatment arms, time, and scales.

Results: Baseline and 1-year Seattle Angina Questionnaire, EQ visual analog scale, short physical performance battery, and clinical frailty scale were collected in around two-thirds of the entire FIRE study population. The mean age was 80.9±4.6 years (female sex, 35.9%). Overall, 35.3% were admitted for ST-segment-elevation myocardial infarction, whereas the others were admitted for non-ST-segment-elevation myocardial infarction. Physiology-guided complete revascularization, compared with culprit-only revascularization, was associated with greater improvement in terms of angina status (Seattle Angina Questionnaire summary score, 7.3 [95% CI, 6.1-8.6] points), health-related quality of life (EQ visual analog scale, 6.2 [95% CI, 4.4-8.1] points), and physical performance (short physical performance battery, 1.1 [95% CI, 0.9-1.3] points). After 1 year, patients randomized to culprit-only revascularization experienced a deterioration in frailty status (clinical frailty scale, 0.2 [95% CI, 0.1-0.3] points), which was not observed in patients randomized to physiology-guided complete revascularization.

Conclusions: The present analysis suggested that a physiology-guided complete revascularization is associated with consistent benefits in terms of angina status, quality of life, physical performance, and the absence of further deterioration of the frailty status.

Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03772743.

研究背景FIRE试验(多血管疾病老年心肌梗死患者功能评估)在意大利、西班牙和波兰招募了1445名患有心肌梗死和多血管疾病的老年患者(年龄≥75岁)。患者被随机分配接受生理学指导下的完全血管再通或治疗唯一的罪魁祸首病变。生理学指导下的完全血运重建大大减少了1年后的缺血性不良事件。本预设分析调查了两个研究组在心绞痛状态、生活质量、体能表现和虚弱程度方面的变化:患者在出院时(基线)和1年后接受了有效的量表测试。心绞痛状况采用西雅图心绞痛问卷进行评估,健康相关生活质量采用 EQ 视觉模拟量表进行评估,体能表现采用短期体能表现量表进行评估,虚弱程度采用临床虚弱量表进行评估。采用混合模型进行重复测量分析,研究治疗组、时间和量表之间的关联:在整个 FIRE 研究人群中,约有三分之二的人接受了基线和 1 年西雅图心绞痛问卷调查、EQ 视觉模拟量表、短期体能测试和临床虚弱量表。平均年龄为(80.9±4.6)岁(女性占 35.9%)。总体而言,35.3%的患者因ST段抬高型心肌梗死入院,其他患者则因非ST段抬高型心肌梗死入院。生理学指导下的完全血运重建与单纯罪魁祸首血运重建相比,在心绞痛状态(西雅图心绞痛问卷总分,7.3[95% CI,6.1-8.6]分)、健康相关生活质量(EQ视觉模拟量表,6.2[95% CI,4.4-8.1]分)和体能(短期体能测试,1.1[95% CI,0.9-1.3]分)方面都有更大改善。1年后,随机接受仅罪魁祸首血运重建的患者的虚弱状态(临床虚弱量表,0.2 [95% CI, 0.1-0.3]分)有所恶化,而随机接受生理学指导下完全血运重建的患者没有观察到这种情况:目前的分析表明,生理指导下的完全血管再通与心绞痛状态、生活质量、体能表现以及虚弱状态不再进一步恶化方面的持续获益相关:URL:https://www.clinicaltrials.gov;唯一标识符:NCT03772743。
{"title":"Health-Status Outcomes in Older Patients With Myocardial Infarction: Physiology-Guided Complete Revascularization Versus Culprit-Only Strategy.","authors":"Gianluca Campo, Vincenzo Guiducci, Javier Escaned, Raul Moreno, Gianni Casella, Caterina Cavazza, Enrico Cerrato, Marco Contarini, Marco Arena, Andres Iniguez Romo, Enrique Gutiérrez Ibañes, Roberto Scarsini, Giuseppe Vadalà, Giuseppe Andò, Gerlando Pilato, Sergio Musto d'Amore, Alessandro Capecchi, Ramiro Trillo Nouche, Elisabetta Moscarella, Alfonso Gambino, Marco Pavani, Anna Zanetti, Nicola Pesenti, Dariusz Dudek, Emanuele Barbato, Matteo Tebaldi, Simone Biscaglia","doi":"10.1161/CIRCOUTCOMES.123.010490","DOIUrl":"10.1161/CIRCOUTCOMES.123.010490","url":null,"abstract":"<p><strong>Background: </strong>The FIRE trial (Functional Assessment in Elderly Myocardial Infarction Patients With Multivessel Disease) enrolled 1445 older (aged ≥75 years) patients with myocardial infarction and multivessel disease in Italy, Spain, and Poland. Patients were randomized to physiology-guided complete revascularization or treatment of the only culprit lesion. Physiology-guided complete revascularization significantly reduced ischemic adverse events at 1 year. This prespecified analysis investigated the changes between the 2 study groups in angina status, quality of life, physical performance, and frailty.</p><p><strong>Methods: </strong>Patients underwent validated scales at hospital discharge (baseline) and 1 year later. Angina status was evaluated using the Seattle Angina Questionnaire, health-related quality of life by EQ visual analog scale, physical performance by short physical performance battery, and frailty by the clinical frailty scale. Mixed models for repeated measures analysis were used to study the association between the treatment arms, time, and scales.</p><p><strong>Results: </strong>Baseline and 1-year Seattle Angina Questionnaire, EQ visual analog scale, short physical performance battery, and clinical frailty scale were collected in around two-thirds of the entire FIRE study population. The mean age was 80.9±4.6 years (female sex, 35.9%). Overall, 35.3% were admitted for ST-segment-elevation myocardial infarction, whereas the others were admitted for non-ST-segment-elevation myocardial infarction. Physiology-guided complete revascularization, compared with culprit-only revascularization, was associated with greater improvement in terms of angina status (Seattle Angina Questionnaire summary score, 7.3 [95% CI, 6.1-8.6] points), health-related quality of life (EQ visual analog scale, 6.2 [95% CI, 4.4-8.1] points), and physical performance (short physical performance battery, 1.1 [95% CI, 0.9-1.3] points). After 1 year, patients randomized to culprit-only revascularization experienced a deterioration in frailty status (clinical frailty scale, 0.2 [95% CI, 0.1-0.3] points), which was not observed in patients randomized to physiology-guided complete revascularization.</p><p><strong>Conclusions: </strong>The present analysis suggested that a physiology-guided complete revascularization is associated with consistent benefits in terms of angina status, quality of life, physical performance, and the absence of further deterioration of the frailty status.</p><p><strong>Registration: </strong>URL: https://www.clinicaltrials.gov; Unique identifier: NCT03772743.</p>","PeriodicalId":49221,"journal":{"name":"Circulation-Cardiovascular Quality and Outcomes","volume":" ","pages":"e010490"},"PeriodicalIF":6.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141421554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Race, Trust, and Medical Decision-Making for Implantable Cardioverter Defibrillators: Do Black Patients Trust the Messenger? 种族、信任与植入式心律转复除颤器的医疗决策:黑人患者信任信使吗?
IF 6.2 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-07-01 Epub Date: 2024-06-12 DOI: 10.1161/CIRCOUTCOMES.124.011142
Favour Markson, Kevin F Kwaku
{"title":"Race, Trust, and Medical Decision-Making for Implantable Cardioverter Defibrillators: Do Black Patients Trust the Messenger?","authors":"Favour Markson, Kevin F Kwaku","doi":"10.1161/CIRCOUTCOMES.124.011142","DOIUrl":"10.1161/CIRCOUTCOMES.124.011142","url":null,"abstract":"","PeriodicalId":49221,"journal":{"name":"Circulation-Cardiovascular Quality and Outcomes","volume":" ","pages":"e011142"},"PeriodicalIF":6.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141307156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assisting Black Patients With Decision-Making for Implantable Cardioverter Defibrillator Therapy: Qualitative Findings From the Videos to Reduce Racial Disparities in ICD Therapy via Innovative Designs (VIVID) Trial. 协助黑人患者做出植入式心律转复除颤器治疗的决策:通过创新设计减少 ICD 治疗中的种族差异视频(VIVID)试验的定性研究结果。
IF 6.2 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-07-01 Epub Date: 2024-06-12 DOI: 10.1161/CIRCOUTCOMES.123.010550
Larry R Jackson, Kevin McKenna, Amy Corneli, Carrie Dombeck, Kathleen Brelsford, Kevin L Thomas

Background: The VIVID (Videos for Addressing Racial Disparities in Implantable Cardioverter Defibrillator Therapy via Innovative Designs) study was a multicenter, randomized controlled trial aimed at evaluating the effectiveness of a video-based decision support tool in enhancing informed consent for implantable cardioverter defibrillator (ICD) implantation among Black patients who met guideline criteria for primary prevention ICDs. Within the broader VIVID randomized trial, a qualitative investigation was conducted to elucidate the decisional factors among Black individuals considering ICD implantation for the primary prevention of sudden cardiac arrest.

Methods: Between October 2016 and July 2019, in-depth interviews were conducted at 2 time points from randomization, ≈7 days (time interval for the decision) and at 90 days; the time interval for determining ICD implantation. Interview findings were categorized by randomized groups, those assigned to 1 of the 2 encounter-based video decision support tools or standard care (without video). Interview participants were purposefully selected to ensure diversity across gender, age, educational background, research site, and randomization group; participants were sampled from 14 academic and community-based electrophysiology clinics in the United States. Data analysis employed applied thematic analysis techniques.

Results: A diverse sample of Black individuals were interviewed at 1 week (n=59; female, 37.3%) and 90 days (n=48; female, 39.6%). The primary factors influencing the decisions of Black individuals considering a primary prevention ICD implantation were (1) their clinicians' recommendations for ICD implantation; (2) their perception of their cardiac health status; and (3) a desire to prolong their lives for the sake of their families.

Conclusions: These findings offer valuable insights that may guide clinicians in their communication with Black patients during shared decision-making encounters related to ICD implantation.

研究背景VIVID(通过创新设计解决植入式心律转复除颤器治疗中种族差异的视频)研究是一项多中心随机对照试验,旨在评估基于视频的决策支持工具在提高符合一级预防ICD指南标准的黑人患者植入植入式心律转复除颤器(ICD)知情同意的有效性。在更广泛的 VIVID 随机试验范围内,我们开展了一项定性调查,以阐明考虑植入 ICD 用于心脏骤停一级预防的黑人患者的决策因素:方法:2016 年 10 月至 2019 年 7 月期间,在随机化后的两个时间点,即≈7 天(决定的时间间隔)和 90 天(决定 ICD 植入的时间间隔)进行了深入访谈。访谈结果按随机分组进行分类,即分配到 2 种基于会诊的视频决策支持工具中的 1 种或标准护理(无视频)组。访谈参与者经过精心挑选,以确保性别、年龄、教育背景、研究地点和随机分组的多样性;访谈参与者来自美国 14 家学术和社区电生理学诊所。数据分析采用了应用主题分析技术:在 1 周(人数=59;女性,占 37.3%)和 90 天(人数=48;女性,占 39.6%)时对不同的黑人进行了访谈。影响黑人考虑植入一级预防 ICD 决定的主要因素有:(1)临床医生对植入 ICD 的建议;(2)他们对自己心脏健康状况的看法;(3)为了家人延长生命的愿望:这些发现提供了宝贵的见解,可指导临床医生在与黑人患者就 ICD 植入进行共同决策时与他们进行沟通。
{"title":"Assisting Black Patients With Decision-Making for Implantable Cardioverter Defibrillator Therapy: Qualitative Findings From the Videos to Reduce Racial Disparities in ICD Therapy via Innovative Designs (VIVID) Trial.","authors":"Larry R Jackson, Kevin McKenna, Amy Corneli, Carrie Dombeck, Kathleen Brelsford, Kevin L Thomas","doi":"10.1161/CIRCOUTCOMES.123.010550","DOIUrl":"10.1161/CIRCOUTCOMES.123.010550","url":null,"abstract":"<p><strong>Background: </strong>The VIVID (Videos for Addressing Racial Disparities in Implantable Cardioverter Defibrillator Therapy via Innovative Designs) study was a multicenter, randomized controlled trial aimed at evaluating the effectiveness of a video-based decision support tool in enhancing informed consent for implantable cardioverter defibrillator (ICD) implantation among Black patients who met guideline criteria for primary prevention ICDs. Within the broader VIVID randomized trial, a qualitative investigation was conducted to elucidate the decisional factors among Black individuals considering ICD implantation for the primary prevention of sudden cardiac arrest.</p><p><strong>Methods: </strong>Between October 2016 and July 2019, in-depth interviews were conducted at 2 time points from randomization, ≈7 days (time interval for the decision) and at 90 days; the time interval for determining ICD implantation. Interview findings were categorized by randomized groups, those assigned to 1 of the 2 encounter-based video decision support tools or standard care (without video). Interview participants were purposefully selected to ensure diversity across gender, age, educational background, research site, and randomization group; participants were sampled from 14 academic and community-based electrophysiology clinics in the United States. Data analysis employed applied thematic analysis techniques.</p><p><strong>Results: </strong>A diverse sample of Black individuals were interviewed at 1 week (n=59; female, 37.3%) and 90 days (n=48; female, 39.6%). The primary factors influencing the decisions of Black individuals considering a primary prevention ICD implantation were (1) their clinicians' recommendations for ICD implantation; (2) their perception of their cardiac health status; and (3) a desire to prolong their lives for the sake of their families.</p><p><strong>Conclusions: </strong>These findings offer valuable insights that may guide clinicians in their communication with Black patients during shared decision-making encounters related to ICD implantation.</p>","PeriodicalId":49221,"journal":{"name":"Circulation-Cardiovascular Quality and Outcomes","volume":" ","pages":"e010550"},"PeriodicalIF":6.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141307155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Text Messages to Promote Physical Activity in Patients With Cardiovascular Disease: A Micro-Randomized Trial of a Just-In-Time Adaptive Intervention. 促进心血管疾病患者体育锻炼的短信:及时适应性干预的微型随机试验。
IF 6.2 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-07-01 Epub Date: 2024-06-18 DOI: 10.1161/CIRCOUTCOMES.123.010731
Jessica R Golbus, Jieru Shi, Kashvi Gupta, Rachel Stevens, V Swetha E Jeganathan, Evan Luff, Thomas Boyden, Bhramar Mukherjee, Sarah Kohnstamm, Vlad Taralunga, Vik Kheterpal, Sachin Kheterpal, Kenneth Resnicow, Susan Murphy, Walter Dempsey, Predrag Klasnja, Brahmajee K Nallamothu

Background: Text messages may enhance physical activity levels in patients with cardiovascular disease, including those enrolled in cardiac rehabilitation. However, the independent and long-term effects of text messages remain uncertain.

Methods: The VALENTINE study (Virtual Application-supported Environment to Increase Exercise) was a micro-randomized trial that delivered text messages through a smartwatch (Apple Watch or Fitbit Versa) to participants initiating cardiac rehabilitation. Participants were randomized 4× per day over 6-months to receive no text message or a message encouraging low-level physical activity. Text messages were tailored on contextual factors (eg, weather). Our primary outcome was step count 60 minutes following a text message, and we used a centered and weighted least squares mean method to estimate causal effects. Given potential measurement differences between devices determined a priori, data were assessed separately for Apple Watch and Fitbit Versa users over 3 time periods corresponding to the initiation (0-30 days), maintenance (31-120 days), and completion (121-182 days) of cardiac rehabilitation.

Results: One hundred eight participants were included with 70 552 randomizations over 6 months; mean age was 59.5 (SD, 10.7) years with 36 (32.4%) female and 68 (63.0%) Apple Watch participants. For Apple Watch participants, text messages led to a trend in increased step count by 10% in the 60-minutes following a message during days 1 to 30 (95% CI, -1% to +20%), with no effect from days 31 to 120 (+1% [95% CI, -4% to +5%]), and a significant 6% increase during days 121 to 182 (95% CI, +0% to +11%). For Fitbit users, text messages significantly increased step count by 17% (95% CI, +7% to +28%) in the 60-minutes following a message in the first 30 days of the study with no effect subsequently.

Conclusions: In patients undergoing cardiac rehabilitation, contextually tailored text messages may increase physical activity, but this effect varies over time and by device.

Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT04587882.

背景:短信可提高心血管疾病患者(包括参加心脏康复的患者)的体育锻炼水平。然而,短信的独立效果和长期效果仍不确定:VALENTINE研究(虚拟应用支持环境增加锻炼)是一项微型随机试验,通过智能手表(Apple Watch或Fitbit Versa)向开始心脏康复的参与者发送短信。在 6 个月的时间里,参与者被随机分配到每天 4 次不接收短信或接收鼓励低水平体育锻炼短信的环境中。短信是根据环境因素(如天气)定制的。我们的主要结果是收到短信后 60 分钟内的步数,我们采用了居中加权最小二乘法来估计因果效应。考虑到事先确定的不同设备之间可能存在的测量差异,我们分别评估了 Apple Watch 和 Fitbit Versa 用户在心脏康复开始(0-30 天)、维持(31-120 天)和完成(121-182 天)3 个时间段内的数据:在 6 个月的时间里,共有 108 名参与者参与了 70 552 次随机测试;平均年龄为 59.5 岁(标准差为 10.7 岁),其中女性 36 人(32.4%),Apple Watch 参与者 68 人(63.0%)。对于 Apple Watch 参与者来说,在收到短信后的 60 分钟内,第 1 天至第 30 天的步数有增加 10%(95% CI,-1% 至 +20%)的趋势,第 31 天至第 120 天没有影响(+1% [95% CI,-4% 至 +5%]),第 121 天至第 182 天显著增加 6%(95% CI,+0% 至 +11%)。对于 Fitbit 用户来说,在研究的前 30 天,短信发出后的 60 分钟内,步数明显增加了 17%(95% CI,+7% 至 +28%),随后则没有影响:结论:在接受心脏康复治疗的患者中,根据情境定制的短信可能会增加体育锻炼,但这种效果会随着时间和设备的不同而变化:URL:https://www.clinicaltrials.gov;唯一标识符:NCT04587882。
{"title":"Text Messages to Promote Physical Activity in Patients With Cardiovascular Disease: A Micro-Randomized Trial of a Just-In-Time Adaptive Intervention.","authors":"Jessica R Golbus, Jieru Shi, Kashvi Gupta, Rachel Stevens, V Swetha E Jeganathan, Evan Luff, Thomas Boyden, Bhramar Mukherjee, Sarah Kohnstamm, Vlad Taralunga, Vik Kheterpal, Sachin Kheterpal, Kenneth Resnicow, Susan Murphy, Walter Dempsey, Predrag Klasnja, Brahmajee K Nallamothu","doi":"10.1161/CIRCOUTCOMES.123.010731","DOIUrl":"10.1161/CIRCOUTCOMES.123.010731","url":null,"abstract":"<p><strong>Background: </strong>Text messages may enhance physical activity levels in patients with cardiovascular disease, including those enrolled in cardiac rehabilitation. However, the independent and long-term effects of text messages remain uncertain.</p><p><strong>Methods: </strong>The VALENTINE study (Virtual Application-supported Environment to Increase Exercise) was a micro-randomized trial that delivered text messages through a smartwatch (Apple Watch or Fitbit Versa) to participants initiating cardiac rehabilitation. Participants were randomized 4× per day over 6-months to receive no text message or a message encouraging low-level physical activity. Text messages were tailored on contextual factors (eg, weather). Our primary outcome was step count 60 minutes following a text message, and we used a centered and weighted least squares mean method to estimate causal effects. Given potential measurement differences between devices determined a priori, data were assessed separately for Apple Watch and Fitbit Versa users over 3 time periods corresponding to the initiation (0-30 days), maintenance (31-120 days), and completion (121-182 days) of cardiac rehabilitation.</p><p><strong>Results: </strong>One hundred eight participants were included with 70 552 randomizations over 6 months; mean age was 59.5 (SD, 10.7) years with 36 (32.4%) female and 68 (63.0%) Apple Watch participants. For Apple Watch participants, text messages led to a trend in increased step count by 10% in the 60-minutes following a message during days 1 to 30 (95% CI, -1% to +20%), with no effect from days 31 to 120 (+1% [95% CI, -4% to +5%]), and a significant 6% increase during days 121 to 182 (95% CI, +0% to +11%). For Fitbit users, text messages significantly increased step count by 17% (95% CI, +7% to +28%) in the 60-minutes following a message in the first 30 days of the study with no effect subsequently.</p><p><strong>Conclusions: </strong>In patients undergoing cardiac rehabilitation, contextually tailored text messages may increase physical activity, but this effect varies over time and by device.</p><p><strong>Registration: </strong>URL: https://www.clinicaltrials.gov; Unique identifier: NCT04587882.</p>","PeriodicalId":49221,"journal":{"name":"Circulation-Cardiovascular Quality and Outcomes","volume":" ","pages":"e010731"},"PeriodicalIF":6.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11251861/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141421517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic Impact of Heart Rhythm Shockability Trajectory in Out-of-Hospital Cardiac Arrest: A Multicenter Retrospective Study. 院外心脏骤停患者心律失常可电击性轨迹的预后影响:一项多中心回顾性研究
IF 6.2 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-07-01 Epub Date: 2024-05-17 DOI: 10.1161/CIRCOUTCOMES.123.010649
Chih-Hung Wang, Tsung-Chien Lu, Joyce Tay, Cheng-Yi Wu, Meng-Che Wu, Pei-I Su, Chun-Yen Huang, Chu-Lin Tsai, Chien-Hua Huang, Wen-Jone Chen

Background: This study aimed to investigate the association between the temporal transitions in heart rhythms during cardiopulmonary resuscitation (CPR) and outcomes after out-of-hospital cardiac arrest.

Methods: This was an analysis of the prospectively collected databases in 3 academic hospitals in northern and central Taiwan. Adult patients with out-of-hospital cardiac arrest transported by emergency medical service between 2015 and 2022 were included. Favorable neurological recovery and survival to hospital discharge were the primary and secondary outcomes, respectively. Time-specific heart rhythm shockability was defined as the probability of shockable rhythms at a particular time point during CPR. The temporal changes in the time-specific heart rhythm shockability were calculated by group-based trajectory modeling. Multivariable logistic regression analyses were performed to examine the association between the trajectory group and outcomes. Subgroup analyses examined the effects of extracorporeal CPR in different trajectories.

Results: The study comprised 2118 patients. The median patient age was 69.1 years, and 1376 (65.0%) patients were male. Three distinct trajectories were identified: high-shockability (52 patients; 2.5%), intermediate-shockability (262 patients; 12.4%), and low-shockability (1804 patients; 85.2%) trajectories. The median proportion of shockable rhythms over the course of CPR for the 3 trajectories was 81.7% (interquartile range, 73.2%-100.0%), 26.7% (interquartile range, 16.7%-37.5%), and 0% (interquartile range, 0%-0%), respectively. The multivariable analysis indicated both intermediate- and high-shockability trajectories were associated with favorable neurological recovery (intermediate-shockability: adjusted odds ratio [aOR], 4.98 [95% CI, 2.34-10.59]; high-shockability: aOR, 5.40 [95% CI, 2.03-14.32]) and survival (intermediate-shockability: aOR, 2.46 [95% CI, 1.44-4.18]; high-shockability: aOR, 2.76 [95% CI, 1.20-6.38]). The subgroup analysis further indicated extracorporeal CPR was significantly associated with favorable neurological outcomes (aOR, 4.06 [95% CI, 1.11-14.81]) only in the intermediate-shockability trajectory.

Conclusions: Heart rhythm shockability trajectories were associated with out-of-hospital cardiac arrest outcomes, which may be a supplementary factor in guiding the allocation of medical resources, such as extracorporeal CPR.

背景:本研究旨在探讨心肺复苏(CPR)过程中心律的时间转换与院外心脏骤停后的预后之间的关系:本研究旨在探讨心肺复苏(CPR)过程中心律的时间转换与院外心脏骤停后的预后之间的关系:这是一项对台湾北部和中部 3 家学术医院前瞻性收集的数据库进行的分析。研究纳入了 2015 年至 2022 年间由急救医疗服务转运的院外心脏骤停成人患者。良好的神经功能恢复和出院存活率分别是主要和次要结果。时间特异性心律可电击性定义为心肺复苏过程中特定时间点出现可电击心律的概率。时间特异性心律可电击性的时间变化是通过基于组的轨迹模型计算得出的。进行了多变量逻辑回归分析,以检验轨迹组与结果之间的关联。亚组分析研究了不同轨迹中体外心肺复苏的效果:结果:该研究包括 2118 名患者。患者年龄中位数为 69.1 岁,男性患者为 1376 人(65.0%)。确定了三种不同的轨迹:高可电击性(52 名患者;2.5%)、中等可电击性(262 名患者;12.4%)和低可电击性(1804 名患者;85.2%)轨迹。在心肺复苏过程中,这三种轨迹的可电击节律中位比例分别为 81.7%(四分位数间距为 73.2%-100.0%)、26.7%(四分位数间距为 16.7%-37.5%)和 0%(四分位数间距为 0%-0%)。多变量分析表明,中度休克和高度休克轨迹均与良好的神经功能恢复有关(中度休克:调整赔率比 [aOR],4.98 [95% CI,2.34-10.59];高度休克:aOR,5.40 [95% CI,2.03-14.32])和存活率有关(中度休克:aOR,2.46 [95% CI,1.44-4.18];高度休克:aOR,2.76 [95% CI,1.20-6.38])。亚组分析进一步表明,只有在中度休克轨迹中,体外心肺复苏才与良好的神经系统预后显著相关(aOR,4.06 [95% CI,1.11-14.81]):结论:心律休克轨迹与院外心脏骤停的预后有关,这可能是指导医疗资源(如体外心肺复苏)分配的辅助因素。
{"title":"Prognostic Impact of Heart Rhythm Shockability Trajectory in Out-of-Hospital Cardiac Arrest: A Multicenter Retrospective Study.","authors":"Chih-Hung Wang, Tsung-Chien Lu, Joyce Tay, Cheng-Yi Wu, Meng-Che Wu, Pei-I Su, Chun-Yen Huang, Chu-Lin Tsai, Chien-Hua Huang, Wen-Jone Chen","doi":"10.1161/CIRCOUTCOMES.123.010649","DOIUrl":"10.1161/CIRCOUTCOMES.123.010649","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to investigate the association between the temporal transitions in heart rhythms during cardiopulmonary resuscitation (CPR) and outcomes after out-of-hospital cardiac arrest.</p><p><strong>Methods: </strong>This was an analysis of the prospectively collected databases in 3 academic hospitals in northern and central Taiwan. Adult patients with out-of-hospital cardiac arrest transported by emergency medical service between 2015 and 2022 were included. Favorable neurological recovery and survival to hospital discharge were the primary and secondary outcomes, respectively. Time-specific heart rhythm shockability was defined as the probability of shockable rhythms at a particular time point during CPR. The temporal changes in the time-specific heart rhythm shockability were calculated by group-based trajectory modeling. Multivariable logistic regression analyses were performed to examine the association between the trajectory group and outcomes. Subgroup analyses examined the effects of extracorporeal CPR in different trajectories.</p><p><strong>Results: </strong>The study comprised 2118 patients. The median patient age was 69.1 years, and 1376 (65.0%) patients were male. Three distinct trajectories were identified: high-shockability (52 patients; 2.5%), intermediate-shockability (262 patients; 12.4%), and low-shockability (1804 patients; 85.2%) trajectories. The median proportion of shockable rhythms over the course of CPR for the 3 trajectories was 81.7% (interquartile range, 73.2%-100.0%), 26.7% (interquartile range, 16.7%-37.5%), and 0% (interquartile range, 0%-0%), respectively. The multivariable analysis indicated both intermediate- and high-shockability trajectories were associated with favorable neurological recovery (intermediate-shockability: adjusted odds ratio [aOR], 4.98 [95% CI, 2.34-10.59]; high-shockability: aOR, 5.40 [95% CI, 2.03-14.32]) and survival (intermediate-shockability: aOR, 2.46 [95% CI, 1.44-4.18]; high-shockability: aOR, 2.76 [95% CI, 1.20-6.38]). The subgroup analysis further indicated extracorporeal CPR was significantly associated with favorable neurological outcomes (aOR, 4.06 [95% CI, 1.11-14.81]) only in the intermediate-shockability trajectory.</p><p><strong>Conclusions: </strong>Heart rhythm shockability trajectories were associated with out-of-hospital cardiac arrest outcomes, which may be a supplementary factor in guiding the allocation of medical resources, such as extracorporeal CPR.</p>","PeriodicalId":49221,"journal":{"name":"Circulation-Cardiovascular Quality and Outcomes","volume":" ","pages":"e010649"},"PeriodicalIF":6.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140960402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiovascular Disease Prevention With mHealth Innovations: Transforming Wellness Through Wireless. 利用移动医疗创新预防心血管疾病:通过无线改变健康。
IF 6.2 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-07-01 Epub Date: 2024-06-18 DOI: 10.1161/CIRCOUTCOMES.124.011005
Safi U Khan
{"title":"Cardiovascular Disease Prevention With mHealth Innovations: Transforming Wellness Through Wireless.","authors":"Safi U Khan","doi":"10.1161/CIRCOUTCOMES.124.011005","DOIUrl":"10.1161/CIRCOUTCOMES.124.011005","url":null,"abstract":"","PeriodicalId":49221,"journal":{"name":"Circulation-Cardiovascular Quality and Outcomes","volume":" ","pages":"e011005"},"PeriodicalIF":6.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141421553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Past, Present, and Future of Shared Decision-Making. 共同决策的过去、现在和未来。
IF 6.2 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-07-01 Epub Date: 2024-07-16 DOI: 10.1161/CIRCOUTCOMES.124.010584
Daniel D Matlock, Larry R Jackson, Amneet Sandhu, Laura D Scherer
{"title":"Past, Present, and Future of Shared Decision-Making.","authors":"Daniel D Matlock, Larry R Jackson, Amneet Sandhu, Laura D Scherer","doi":"10.1161/CIRCOUTCOMES.124.010584","DOIUrl":"https://doi.org/10.1161/CIRCOUTCOMES.124.010584","url":null,"abstract":"","PeriodicalId":49221,"journal":{"name":"Circulation-Cardiovascular Quality and Outcomes","volume":"17 7","pages":"e010584"},"PeriodicalIF":6.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141628152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recurring and Emerging Ethical Issues in Pragmatic Clinical Trials. 实用临床试验中反复出现和新出现的伦理问题。
IF 6.2 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-07-01 Epub Date: 2024-07-16 DOI: 10.1161/CIRCOUTCOMES.124.010847
Caleigh Propes, P Pearl O'Rourke, Stephanie R Morain
{"title":"Recurring and Emerging Ethical Issues in Pragmatic Clinical Trials.","authors":"Caleigh Propes, P Pearl O'Rourke, Stephanie R Morain","doi":"10.1161/CIRCOUTCOMES.124.010847","DOIUrl":"10.1161/CIRCOUTCOMES.124.010847","url":null,"abstract":"","PeriodicalId":49221,"journal":{"name":"Circulation-Cardiovascular Quality and Outcomes","volume":"17 7","pages":"e010847"},"PeriodicalIF":6.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11254325/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141628153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Circulation-Cardiovascular Quality and Outcomes
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1